DocDollars

Merz Pharmaceuticals, LLC

NC · United States · Reporting entity ID 100000005377

Total reported 2019–2025
$9.04M
#524 of 2,960 reporting companies — 0% of all reported industry payments
$4.35M in general payments across 31,816 records, plus $4.68M in research funding across 567 records.

How it breaks down

General payments $4,353,742
Research funding $4,684,985

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Merz Pharmaceuticals, LLC reported $9.04M to US doctors and teaching hospitals from 2019 to 2025, ranking #524 of 2,960 reporting companies. 52% of that was research funding and 48% general payments such as consulting, speaking, food and travel. 31,816 general payment records and 567 research records were filed.

Common questions about Merz Pharmaceuticals, LLC

How much has Merz Pharmaceuticals, LLC paid US doctors?

Merz Pharmaceuticals, LLC reported $9,038,727 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,353,742 in general payments, $4,684,985 in research funding.

How does Merz Pharmaceuticals, LLC rank among drug and device companies?

It ranks #524 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Merz Pharmaceuticals, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.